Controversies in the Pandemic

Joseph Varon MD FACP FCCP FCCM FRSMProfessor, The University of Houston College of Medicine, Houston, Texas, USAPaul E Marik MD MBBSChief Medical Officer, Front Line Critical Care Consortium, FLCCC Alliance, Washington DC, USAMarc Rendell MDMedical Director, The Rose Salter Medical Research Foundation, Newport Coast, California, USAJose Iglesias DO FASNDepartment of Medicine, Rutgers Health/Community Medical Centre, Internal Medicine Residency Program, Community Medical Centre, RWJBH, Toms River, New Jersey, USAChristopher de Souza DORL MS DNB FACS (USA) FRCS (England) FRCS (Ireland) Fellow of the American Neurotology Society Doctor of Literature (Honoris Causa)Maharashtra University of Health Sciences, Nashik, Maharashtra, IndiaPrahlad Prabhudesai MBBS MD DNB FCCPConsultant in Pulmonary Medicine, Lilavati Hospital and Research Centre, Mumbai, Maharashtra, India

• SECTION 1: CONTROVERSIESCHAPTER 1: IntroductionCHAPTER 2: The Totality of EvidenceCHAPTER 3: COVID-19 Censorship in the European Union: The Example of AustriaCHAPTER 4: COVID-19, Hydroxychloroquine, Politics, and Scientific Author Political Party Donation History—What could Possibly Go Wrong?CHAPTER 5: “You are not a Horse”: Medicalization, Social Control, and Academic Discourse in the COVID-19 EraCHAPTER 6: Origin of COVID Pandemic: A Natural Calamity or Manmade AdventureCHAPTER 7: Origins of COVID through the Indian ContextCHAPTER 8: Gain-of-function and Origin of COVID-19CHAPTER 9: The Enigma of the 1889 Russian Flu Pandemic: A Coronavirus? SECTION 2: NONPHARMACOLOGIC INTERVENTIONS CHAPTER 10: The Use of Masks in the Prevention of SARS-CoV-2 TransmissionCHAPTER 11: Managing COVID-19 in Hong Kong: Lessons from SARS 2003 and Effective Strategies for ControlCHAPTER 12: COVID-19 and DentistryCHAPTER 13: The Evolving Role of Simulation in Surgical TrainingCHAPTER 14: The Impact of the COVID-19 Pandemic on NursingCHAPTER 15: Immunology in COVID-19CHAPTER 16: The Experience in the Making of COVID-19 VaccinesCHAPTER 17: Controversies Concerning the Immunology of the COVID-19 Adaptive Immunity VaccinesCHAPTER 18: The COVID-19 Vaccine SECTION 3: SPECIAL ISSUE OF INTEREST CHAPTER 19: The Art of LivingCHAPTER 20: Computed Tomography Thorax in COVID Management: A Rightfully Used or Misused Tool?CHAPTER 21: Surgical Education and Training during the COVID-19 Pandemic SECTION 4: THERAPIES CHAPTER 22: The Need to Revisit Hydroxychloroquine in Early Treatment Strategies of COVID-19CHAPTER 23: IvermectinCHAPTER 24: Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19CHAPTER 25: AntiviralsCHAPTER 26: Glucocorticoids in Viral Pneumonia and COVID-19CHAPTER 27: Therapeutic Effects of Fluvoxamine in the Management of COVID-19CHAPTER 28: Randomized Placebo Controlled Trials in the COVID Era: A Question of Faith? SECTION 5: COMPLICATIONS CHAPTER 29: An Update on the Relationship between SARS-CoV-2 (COVID-19) and its Neurological ManifestationsCHAPTER 30: Myocarditis: COVID-19 and COVID-19 VaccinesCHAPTER 31: Injuries from the SARS CoV-2 VaccinesCHAPTER 32: Tracheostomy during COVID-19 Pandemic; To Do or Not To DoCHAPTER 33: Telemedicine for Medical Students—Lessons Learnt from the PandemicCHAPTER 34: Censorship of the Biomedical Literature during the COVID-19 Era